Company intelligence / Profile preview

Ufonia

Oxford, England, United Kingdomufonia.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Ufonia’s “Dora” platform has been deployed to automate routine telephone consultations, improving efficiency and patient access across NHS organizations. The company conducts rigorous studies to ensure safety and quality of care but does not publish traditional drug/device trial results.

Therapeutic areas: Other
Modalities: Device (AI-powered autonomous clinical assistant)
Industry: Digital Health Medical Devices

Partnerships

University of Oxford support

Beyond the preview

Go deeper on Ufonia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ufonia.

Explore the full profile